Clough Capital Partners L P owned approximately 0.18% of TherapeuticsMD worth $2,115,000 as of its most recent filing with the SEC.
A number of other institutional investors also recently modified their holdings of the company. Sphera Funds Management LTD. acquired a new stake in TherapeuticsMD during the first quarter worth approximately $4,176,000. Vanguard Group Inc. increased its position in TherapeuticsMD by 5.6% in the first quarter. Vanguard Group Inc. now owns 9,801,870 shares of the company’s stock worth $70,574,000 after buying an additional 515,992 shares in the last quarter. JPMorgan Chase & Co. increased its position in TherapeuticsMD by 2.5% in the first quarter. JPMorgan Chase & Co. now owns 13,725,853 shares of the company’s stock worth $98,827,000 after buying an additional 329,245 shares in the last quarter. State Street Corp increased its position in TherapeuticsMD by 6.9% in the first quarter. State Street Corp now owns 3,903,491 shares of the company’s stock worth $28,105,000 after buying an additional 253,237 shares in the last quarter. Finally, Stifel Financial Corp increased its position in shares of TherapeuticsMD by 125.4% in the first quarter. Stifel Financial Corp now owns 429,362 shares of the company’s stock valued at $3,091,000 after buying an additional 238,885 shares in the last quarter....
